← Back to Search

Time Restricted Eating + Standard of Care for Prediabetes (TIMET Trial)

N/A
Waitlist Available
Led By Pam Taub, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 14 weeks
Awards & highlights

Summary

This trial will study the health impacts of eating within an 8-10 hour window for 12 weeks, in patients with metabolic syndrome who normally eat for more than 14 hours every day.

Eligible Conditions
  • Prediabetes
  • Metabolic Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 14 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in glucose levels assessed via HbA1c
Change in glycemic parameters
Secondary study objectives
Change in HDL cholesterol
Change in LDL cholesterol
Change in LDL particle number
+3 more
Other study objectives
Change in mitochondrial structure and gene expression in skeletal muscle

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TRE + SOCExperimental Treatment1 Intervention
Everyone in this arm will receive standard of care nutritional behavioral counseling and will implement a daily 8-10-hour window within which they must consume their calories. They will also be required to log their caloric intake through the use of a smartphone app.
Group II: SOC (Standard of Care)Placebo Group1 Intervention
Everyone in this arm will receive standard of care nutritional behavioral counseling and will be required to log their caloric intake through the use of a smartphone app.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Time Restricted Eating + Standard of Care
2018
N/A
~160

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,409 Previous Clinical Trials
4,324,787 Total Patients Enrolled
Salk Institute for Biological StudiesOTHER
20 Previous Clinical Trials
1,833 Total Patients Enrolled
University of California, San DiegoLead Sponsor
1,157 Previous Clinical Trials
1,571,297 Total Patients Enrolled
~19 spots leftby Sep 2025